Clover Health Investments, Corp. (CLOV) 10-Year Financial Performance & Capital Metrics

CLOV • • Insurance & Managed Care

HealthcareHealth InsuranceMedicare Advantage SpecialistsTech-Enabled Medicare Advantage

AboutClover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.Show more

Revenue $1.37B +8.8%
Combined Ratio 103.34% -11.1%
Net Income -$43M +79.8%
Return on Equity -13.71% +79.3%
Medical Cost Ratio 73.39% -7.9%
Operating Margin -3.34% +79.5%
Net Margin -3.14% +81.5%
ROA -7.47% +75.9%
Equity / Assets 58.74% +17.1%
Book Value per Share 0.70 +17.2%
Tangible BV/Share 0.69 +17.4%
Debt/Equity -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y24.29%

3Y-2.34%

TTM14.84%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM36.18%

EPS CAGR

10Y-

5Y-

3Y-

TTM41.72%

ROCE

10Y Avg-110.04%

5Y Avg-100.07%

3Y Avg-44.45%

Latest-13.52%

Peer Comparison

Tech-Enabled Medicare Advantage

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
OSCROscar Health, Inc.	4.38B	17.38	181.61	56.54%	-2.16%	-23.77%	21.67%	0.29
CLOVClover Health Investments, Corp.	1.08B	2.54	-28.93	8.77%	-3.29%	-17.11%	3.09%
ALHCAlignment Healthcare, Inc.	4.19B	20.92	-31.22	48.25%	-0.57%	-12.86%		3.26

Profit & Loss

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Revenue+	281.02M	462.27M	672.89M	1.47B	1.1B	1.26B	1.37B
Revenue Growth %	-	0.64%	0.46%	1.19%	-0.26%	0.15%	0.09%
Medical Costs & Claims+	0	449.7M	590.08M	1.55B	993.07M	1B	1.01B
Medical Cost Ratio %	-	-	-	-	-	-	-
Gross Profit+	281.02M	12.56M	82.81M	-79.18M	103.48M	255.95M	364.8M
Gross Margin %	-	-	-	-	-	-	-
Gross Profit Growth %	-	-0.96%	5.59%	-1.96%	2.31%	1.47%	0.43%
Operating Expenses+	476M	195.76M	175.51M	557.81M	390.14M	461.28M	410.55M
OpEx / Revenue %	-	-	-	-	-	-	-
Depreciation & Amortization	185.8M	551K	555K	1.25M	1.19M	2.51M	1.33M
Combined Ratio %	-	-	-	-	-	-	-
Operating Income+	-185.8M	-183.2M	-92.71M	-636.99M	-286.66M	-205.33M	-45.75M
Operating Margin %	-	-	-	-	-	-	-
Operating Income Growth %	-	0.01%	0.49%	-5.87%	0.55%	0.28%	0.78%
EBITDA+	0	-182.65M	-92.15M	-635.75M	-285.48M	-202.82M	-44.42M
EBITDA Margin %	-	-	-	-	-	-	-
Interest Expense	0	39.07M	57.11M	16.91M	1.36M	7K	0
Non-Operating Income	186.67M	141.47M	-13.42M	-66.15M	-33.44M	4.81M	517K
Pretax Income+	-201.93M	-363.74M	-136.39M	-587.76M	-254.58M	-210.15M	-46.27M
Pretax Margin %	-	-	-	-	-	-	-
Income Tax+	0	0	0	0	0	0	0
Effective Tax Rate %	-	-	-	-	-	-	-
Net Income+	-201.93M	-363.74M	-136.39M	-587.76M	-339.57M	-213.36M	-43.01M
Net Margin %	-	-	-	-	-	-	-
Net Income Growth %	-	-0.8%	0.63%	-3.31%	0.42%	0.37%	0.8%
EPS (Diluted)+	-4.81	-0.90	-0.23	-1.25	-0.71	-0.45	-0.09
EPS Growth %	-	0.81%	0.74%	-4.43%	0.43%	0.37%	0.8%
EPS (Basic)	-4.81	-0.90	-0.23	-1.25	-0.71	-0.45	-0.09
Diluted Shares Outstanding	42.01M	404.44M	404.44M	470.85M	476.24M	482.18M	490.02M

Balance Sheet

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Assets+	210.6M	100.35K	267.25M	950.8M	808.62M	570.67M	580.74M
Asset Growth %	-	-1%	2662.3%	2.56%	-0.15%	-0.29%	0.02%
Total Investment Assets+	0	0	58.76M	491.23M	369.08M	240.82M	228.72M
Long-Term Investments	0	0	54.39M	175.94M	138.11M	121M	201.72M
Short-Term Investments	0	0	4.36M	315.29M	230.97M	119.82M	27M
Total Current Assets+	75.4M	0	189.78M	752.55M	625M	427.97M	343.12M
Cash & Equivalents	75.4M	0	92.35M	299.97M	103.79M	116.41M	194.54M
Receivables	0	0	1000K	1000K	1000K	1000K	1000K
Other Current Assets	0	0	299K	13.18M	104.55M	91.08M	15.62M
Goodwill & Intangibles+	2.99M	0	4.23M	4.23M	20M	2.99M	2.99M
Goodwill	0	0	0	0	11.75M	0	0
Intangible Assets	2.99M	0	4.23M	4.23M	8.25M	2.99M	2.99M
PP&E (Net)	3.21M	0	9.96M	7.65M	9.78M	5.08M	5.31M
Other Assets	128.99M	100.35K	8.88M	10.43M	15.73M	13.63M	27.6M
Total Liabilities	265.42M	117.98K	880.45M	411.49M	451.73M	284.28M	239.6M
Total Debt+	49.25M	0	138.36M	27.83M	5.86M	4.66M	0
Net Debt	-26.15M	0	46.01M	-272.14M	-97.93M	-111.74M	-194.54M
Long-Term Debt	49.25M	0	106.41M	19.94M	0	0	0
Short-Term Debt	0	0	20.8M	0	0	0	0
Total Current Liabilities+	6.03M	117.98K	164.23M	372.62M	431.51M	261.12M	213.52M
Accounts Payable	0	0	30.67M	28.13M	32.45M	37.18M	34.56M
Deferred Revenue	0	0	102.43M	138.6M	0	3.1M	0
Other Current Liabilities	0	0	-102.42M	8.99M	81.57M	61.12M	22.56M
Deferred Taxes	0	0	0	0	0	0	0
Other Liabilities	210.15M	0	603.46M	14.1M	16.19M	20.16M	26.08M
Total Equity+	-54.83M	-17.63K	-613.19M	539.32M	356.89M	286.39M	341.14M
Equity Growth %	-	1%	-34778.25%	1.88%	-0.34%	-0.2%	0.19%
Shareholders Equity	-54.83M	-17.63K	-617.1M	535.41M	356.89M	286.39M	341.14M
Minority Interest	0	0	3.9M	3.9M	0	0	0
Retained Earnings	-527.9M	-17.63K	-1.03B	-1.62B	-1.95B	-2.16B	-2.2B
Common Stock	4K	0	9K	46K	46K	49K	50K
Accumulated OCI	0	0	10K	-1.93M	-9.37M	-2.37M	-1.58M
Return on Equity (ROE)	-	-	-	-1.09%	-0.76%	-0.66%	-0.14%
Return on Assets (ROA)	-0.96%	-3.45%	-1.02%	-0.97%	-0.39%	-0.31%	-0.07%
Equity / Assets	-	-	-	-	-	-	-
Debt / Equity	-	-	-	0.05x	0.02x	0.02x	-
Book Value per Share	-1.31	-0.00	-1.52	1.15	0.75	0.59	0.70
Tangible BV per Share	-	-	-	-	-	-	-

Cash Flow

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-153.28M	-159.88M	-118.5M	-282.33M	-203.93M	-115.87M	34.84M
Operating CF Growth %	-	-0.04%	0.26%	-1.38%	0.28%	0.43%	1.3%
Operating CF / Revenue %	-	-	-	-	-	-	-
Net Income	-201.93M	-363.74M	-136.39M	-587.76M	-339.57M	-213.36M	-43.01M
Depreciation & Amortization	487K	551K	0	1.25M	1.19M	2.51M	1.33M
Stock-Based Compensation	3.68M	3.3M	0	163.72M	164.31M	140.93M	114.33M
Deferred Taxes	0	0	0	-66.09M	0	0	0
Other Non-Cash Items	9.51M	167.7M	42.35M	13.88M	-27.49M	9.48M	-50.66M
Working Capital Changes	34.97M	32.31M	-24.46M	192.67M	-2.36M	-55.43M	12.86M
Cash from Investing+	97.53M	-181.91M	141.31M	-435.45M	95.13M	140.01M	565K
Capital Expenditures	-1.48M	-23K	-693K	-723K	-4.47M	-584K	-1.56M
Acquisitions	0	-1.18M	3.9M	434.72M	-16.2M	0	0
Purchase of Investments	0	-505.55M	-174.32M	-876.25M	-369.65M	-175.57M	-201.24M
Sale/Maturity of Investments	0	1000K	1000K	1000K	1000K	1000K	1000K
Other Investing	99M	0	0	-434.72M	0	0	0
Cash from Financing+	74.59M	333.98M	1.94M	925.39M	-4.96M	-33.86M	-17.36M
Dividends Paid	0	0	0	0	0	0	0
Share Repurchases	0	0	0	-147K	-6.36M	-6.22M	-18.26M
Stock Issued	0	601K	1.75M	289.92M	1.4M	1.15M	902K
Debt Issuance (Net)	1000K	1000K	1000K	-1000K	0	0	0
Other Financing	44.83M	-363K	-957K	666.55M	0	-28.79M	0
Net Change in Cash+	18.83M	-7.8M	92.35M	207.62M	-113.75M	-9.72M	18.05M
Exchange Rate Effect	0	0	1000K	0	0	0	0
Cash at Beginning	56.57M	75.4M	0	92.35M	299.97M	186.21M	176.49M
Cash at End	75.4M	67.6M	92.35M	299.97M	186.21M	176.49M	194.54M
Free Cash Flow+	-154.76M	-159.9M	-119.19M	-283.05M	-208.39M	-116.45M	33.29M
FCF Growth %	-	-0.03%	0.25%	-1.37%	0.26%	0.44%	1.29%
FCF Margin %	-	-	-	-	-	-	-
FCF per Share	-3.68	-0.4	-0.29	-0.6	-0.44	-0.24	0.07

Key Ratios

Metric	2018	2019	2020	2021	2022	2023	2024
Combined Ratio	169.38%	139.63%	113.78%	143.27%	126.14%	116.29%	103.34%
Medical Cost Ratio	0%	97.28%	87.69%	105.38%	90.56%	79.7%	73.39%
Return on Equity (ROE)	-	-	-	-108.98%	-75.78%	-66.34%	-13.71%
Return on Assets (ROA)	-95.88%	-345.27%	-102.03%	-96.51%	-38.6%	-30.94%	-7.47%
Equity / Assets	-26.03%	-17.57%	-229.44%	56.72%	44.14%	50.19%	58.74%
Book Value / Share	-1.31	-0	-1.52	1.15	0.75	0.59	0.7
Debt / Equity	-	-	-	0.05x	0.02x	0.02x	-
Revenue Growth	-	64.49%	45.56%	118.76%	-25.51%	14.96%	8.77%

Revenue by Segment

	2021	2022	2023	2024
Insurance	-	2.58M	10.34M	26.25M
Insurance Growth	-	-	301.09%	153.97%
Non-Insurance	-	2.38B	773.18M	-
Non-Insurance Growth	-	-	-67.52%	-
Direct Contracting Operations	667.64M	-	-	-
Direct Contracting Operations Growth	-	-	-	-

Frequently Asked Questions

Growth & Financials

Clover Health Investments, Corp. (CLOV) grew revenue by 8.8% over the past year. This is steady growth.

Clover Health Investments, Corp. (CLOV) reported a net loss of $58.3M for fiscal year 2024.

Dividend & Returns

Clover Health Investments, Corp. (CLOV) has a return on equity (ROE) of -13.7%. Negative ROE indicates the company is unprofitable.

Industry Metrics

Clover Health Investments, Corp. (CLOV) has a combined ratio of 103.3%. A ratio above 100% means claims and expenses exceed premiums.

← Back to Screener